Comments
Mumbai-based drugmaker Alkem Laboratories is making its ₹1,344-crore public offer from December 8-10.
OFS route The company is placing over 1.28 crore shares on the block through an offer-for-sale by its selling shareholders, the company said in a public advertisement on Tuesday. Each equity share has a face value of ₹2 and is priced at ₹1,0201,050.
The offer includes a reservation of 2.98 lakh shares for employees, who receive a discount of ₹100 on the final offer price.
The total offer constitutes 10.75 per cent of the post-offer paid-up capital of the company. The total offer size is ₹1,305-₹1,344 crore. The minimum bid lot is 14 equity shares and thereafter in multiples of 14. In financial year 2015, it was the fifth-largest pharmaceutical company in India in terms of domestic sales.
Alkem Laboratories manufactures branded generics, generic drugs, active pharmaceutical ingredients and nutraceutical products, and markets the same in India and 55 other countries, primarily the US.
The shares will be listed on the BSE and the NSE. Nomura Financial Advisory and Securities India, Axis Capital, JP Morgan India and Edelweiss Financial Services are the merchant bankers to the issue.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.